Functionalization of pyrazole–tetrazole C–C/N–C isomeric conjugated frameworks: preparation of novel high-energy compounds toward multifunctional applications
Journal of Materials Chemistry A · 2026 · 14 (43) · 28886-28892
DOI: 10.1039/d6ta03565e ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Materials Chemistry A, 2026. Verfasst von Xianfeng Wang und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Association for Science and Technology.
Abstract (Originalsprache)
This work introduces isomeric conjugated framework engineering comparing C–C versus N–C linkages in pyrazole–tetrazole systems to tune packing, H-bonding, π–π interactions, and bond energy. Novel high-performance materials were developed.
Förderung
- National Natural Science Foundation of China
- China Association for Science and Technology
Zitieren
APA
Wang, X., Yang, F., Jiang, S., Lin, Q., Wang, P., Xu, Y., & Lu, M. (2026). Functionalization of pyrazole–tetrazole C–C/N–C isomeric conjugated frameworks: preparation of novel high-energy compounds toward multifunctional applications. Journal of Materials Chemistry A, 14(43), 28886-28892. https://doi.org/10.1039/d6ta03565e
Vancouver
Wang X, Yang F, Jiang S, Lin Q, Wang P, Xu Y, et al. Functionalization of pyrazole–tetrazole C–C/N–C isomeric conjugated frameworks: preparation of novel high-energy compounds toward multifunctional applications. Journal of Materials Chemistry A. 2026;14(43):28886-28892. doi:10.1039/d6ta03565e
BibTeX
@article{Wang2026,
author = {Wang, Xianfeng and Yang, Feng and Jiang, Shuaijie and Lin, Qiuhan and Wang, Pengcheng and Xu, Yuangang and Lu, Ming},
title = {Functionalization of pyrazole–tetrazole C–C/N–C isomeric conjugated frameworks: preparation of novel high-energy compounds toward multifunctional applications},
journal = {Journal of Materials Chemistry A},
year = {2026},
volume = {14},
number = {43},
pages = {28886--28892},
doi = {10.1039/d6ta03565e}
}
EUVIMED